Ernst & Young GMBH, Friedrichstraße 140, Berlin
As medicine grows more specialized and data-driven, the need to adapt and rethink the current medical affairs becomes imperative. At the same time, the health industry is moving to a new paradigm, Medical Affairs 2.0, where data mining combined with medical expertise are becoming critical for R&D and commercial counterparts and its role in product launch is getting strategically crucial. Based on a study presented by Bain company, clinician-scientists have reduced their reliance on pharma sales representatives turning to more scientific sources of information in the healthcare industry. That shift is even more pronounced among younger physicians. In parallel, the total number of sales representatives at big pharmas has fallen in the past years.
The Internet of Things and emerging technologies offer many undeniable advantages to becoming the “new norm”. In regards to clinical research, data can be collected more easily and over longer periods of time. Overall, collaboration, cooperation and transparency will provide the new directions for clinical researchers.
In collaboration with our long-term Health 2.0 Berlin friend Nana Bit-Avragim and some pioneering digital health companies such as Viomedo and Medicinisto, Charité–Universitätsmedizin Berlin, and Ernst & Young Germany, we are going to discuss innovations and current trends in clinical trials to reinvent key opinion leader management and build on value measures and progress towards data-driven, user-centric clinical trials operation.
18:30 Doors open
19:10 Keynote Speaker: Dr. Prateek Mahalwar, Ernst & Young Germany
19:30 Panel Discussion with the following participants:
• Prof. Dr. Marcus Maurer, Charité-Universitätsmedizin Berlin
• Zsuzsanna Varga, PhD, Innovation Manager at Bayer
• Alexander Puschilov, Viomedo GmbH
• Guido Axmann, Medicinisto AG
• Dr. Katarina Braune, Patient Representative
Moderation: Dr. Nana Bit-Avragim, Medicinisto
20:30 Networking with Beer & Pretzels
Prateek Mahalwar, PhD
Manager - Advisory Services, Ernst & Young GmbH http://www.ey.com/de/de/home
Dr. Mahalwar is part of the Advisory Services practice of EY Germany, concentrating on the Life Sciences and Healthcare sector. His work includes advising biotechnology, pharma and MedTech companies on investment, product commercialization and digitization topics. Prateek Mahalwar holds a PhD in Life Science from Max Planck Society, where he was supervised by Nobel Laureate Prof. Christiane Nüsslein-Volhard. Prior to joining EY, Prateek has co-founded digital health and medical device start-up and also served as an advisory board member at eLife Sciences Ltd., UK (Max Planck, HHMI & Welcome Trust). Prateek has numerous years of experience in working with various C-level management executives internationally.
Marcus Maurer, MD
Charité - Universitätsmedizin Berlin, Department of Dermatology and Allergy, Germany, http://www.marcus-maurer.com/index.php?id=837
Marcus Maurer is Professor of Dermatology and Allergy at the Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Germany. He is also the Director of Research at the Department of Dermatology and Allergy, Associate Director of the Allergie-Centrum-Charité, and Head of the Specialty Clinics for angioedema, hereditary angioedema, urticaria, mastocytosis, pruritus, autoinflammatory disorders and the Dermatological Allergology Laboratory. He trained in dermatology and allergology in Berlin and Mainz, and in experimental pathology at the Beth Israel Deaconess Hospital and Harvard Medical School in Boston from 1995 to 1998 and attained his board certification for dermatology in 2000 and allergology in 2003. His habilitation (“Why do we have mast cells?”) was undertaken at the University of Mainz in 2003.
Professor Maurer´s research focuses on physiological and pathological functions of mast cells. He has made numerous important contributions to the understanding of the role of mast cells in the pathogenesis of chronic inflammatory disorders as well as in the protection from infections. His clinical emphasis is on urticaria, mastocytosis, angioedema, hereditary angioedema, pruritus, and auto-inflammatory syndromes.
Lately, Professor Maurer’s team has also followed translational approaches using human in vivo and ex vivo models to investigate the functions of human mast cells, mostly skin mast cells. These investigations have led, among others, to the development of the concept of autoallergy in chronic urticaria, which was critical for the clinical testing and develop of anti-IgE as a novel treatment option in chronic spontaneous urticaria, a treatment that was licensed for the use in this disease in 2014. Professor Maurer’s team, over the past years, built national reference centres for the investigation and treatment of urticaria, mastocytosis, hereditary angioedema, angioedema and other mast cell-driven diseases, and more than 30 randomized controlled trials (phase I through IV) were performed by him and his team since 2011.
Professor Maurer is the author of more than 415 publications in peer reviewed journals including Nature and the New England Journal of Medicine (>21,700 citations, h-index: 76).
Co-Founder and Managing Director of Viomedo https://www.viomedo.de/
Alexander is one of the founders of Viomedo. He is driven by the mission to provide patients with access to tomorrow’s medicine today. Before starting Viomedo, Alexander was amongst others with Rocket Internet and advised leading biotech companies on their market access strategy. He holds a M.Sc. in International Health Policy from the London School of Economics and a B.Sc. in Management from WHU.
Co-Founder and CEO of Medicinisto http://www.medicinisto.com/
A graduate in medicine, Guido Axmann is an entrepreneur, business developer and early-stage investor. He has created and developed several businesses and organizations in healthcare, sustainability and energy. Currently, he serves as co-founder and CEO of Medicinisto, the platform for medical expertise, where medicine meets the healthcare industry.
Katarina Braune, MD
Katarina Braune lives with type 1 diabetes since 2001, wearing a continuous glucose monitoring sensor system and an insulin pump.
From her professional background, she is a medical doctor and researcher at the Department of Paediatric Endocrinology and Diabetes of Charité-Universitätsmedizin Berlin.
Furthermore, she is fighting for global access to insulin and empowering young people to live with diabetes as a global advocate.
She helped to set up Berlin's refugee health unit “Charité hilft” which has provided medical aid to more than 64,000 refugees. For future research projects, her focus is on digital health and telemedicine, building scientifically sound digital health solutions that grow on the real needs of real patients.
Please have a look at Katarina’s story on challenges of refugees living with a chronic disease given by Katarina at TEDxUniHalle: https://youtu.be/A1oyHCOP9Pk
Zsuzsanna Varga, PhD
Innovation Manager at Bayer, Program Manager of Bayer Grants4Apps https://www.grants4apps.com/
Zsuzsanna grew up in Heidelberg, Germany. She holds a Biotechnology degree and obtained her PhD in Biomedical Sciences at the Mount Sinai School of Medicine in New York. During her studies she worked with several biotechnology start-ups and has experience in life sciences for 15 years. At Bayer she has been working as a Business Consultant for Marketing & Sales topics with a focus on digital patient support programs. Zsuzsanna is currently managing the Grants4Apps program for digital health start-ups with the aim to identify business opportunities for Bayer.
Nana Bit-Avragim, MD
Head of Strategic Relations at Medicinisto
Dr. Nana Bit-Avragim is a medical expert, intrapreneur and digital health strategist. Nana is passionate about new life sciences technologies and believes that innovation means adapting to the future. To translate the latest global technological developments into life sciences and align it with the healthcare industry, Nana has successfully developed and executed a broad scope of innovative programs and partnerships between SMEs, NGOs, healthcare industry and academia in her previous roles as Director of Entrepreneurship and Innovation at Charité Foundation and Head of Digital Health & Life Sciences program at the German hub of Singularity University, an executive education organization based on NASA Research Park in Silicon Valley.
Nana is currently leading business development and strategic partnerships at Medicinisto, an international business network for medical experts and healthcare industry.